Suspicious Mole? Private vs NHS: What Happens and How Fast

A new or changing mole needs prompt assessment by someone trained to examine it with dermoscopy. On the NHS that means an urgent suspected cancer referral from your GP; privately at Midland Skin you book directly and are seen by a consultant dermatologist, with a biopsy arranged promptly if one is needed. This article explains what happens at each step on both routes and how long things usually take.

The worry behind a changing mole and why speed matters

A new or changing mole can trigger understandable what-if thoughts. In clinic, we describe a lesion as suspicious when its pattern, colour, border or evolution suggests risk. The first-line tool is dermoscopy, a magnified and polarised light examination that improves accuracy over unaided visual inspection for identifying melanoma and ruling out false alarms.

Two routes, one goal: catching cancer early

NHS standards in plain English

If your GP is concerned about a mole, you are referred on the urgent suspected skin cancer pathway (previously called the “two-week wait”). In England this is measured against the Faster Diagnosis Standard, which aims to diagnose or rule out cancer within 28 days of referral, alongside 31-day and 62-day treatment standards. In many areas the first step is teledermatology: photographs, usually including dermoscopic images, are taken by a medical photographer or trained staff and reviewed remotely by a dermatologist. Depending on the images you may be reassured and discharged, booked straight in for a biopsy, or given a face-to-face clinic appointment where the lesion is examined with dermoscopy.

The private pathway at Midland Skin

Privately, you do not need a GP referral. You choose an appointment time that is prompt and suits you, and you are seen in person by a consultant dermatologist for a consultant-led dermoscopic assessment. If a biopsy is indicated, we discuss the most suitable technique, such as excision, punch or shave, and arrange it promptly under local anaesthetic with clear aftercare and a plan for results. Many suspicious moles are removed on the same day as the consultation where the consultant considers this appropriate; otherwise the procedure is booked promptly.

At a glance: NHS vs private for a suspicious mole

Your first assessment: what actually happens

We begin with your story: what changed, when you noticed it, any symptoms such as itch or bleeding, personal or family skin cancer history, and sun exposure. Then we examine the lesion and, when relevant, the surrounding skin. Dermoscopy reveals subsurface colours and structures that guide whether to watch, image or biopsy. Dermoscopy outperforms visual inspection alone.

Other moles can also be checked at your initial private consultation, and you can even opt to have a full head to toe skin check. You can find out more about our consultant-led mole checks here.

Teledermatology vs face-to-face

Good photographs, sometimes with dermoscopic images, can help triage and prioritise. Accuracy depends on image quality and clinical context. When there is uncertainty, an in-person dermoscopic assessment remains the safer choice.

Biopsy choices, scarring and safety: practical questions

• Excision removes the whole lesion with a margin. This is preferred when melanoma is suspected.
• Punch biopsy takes a core sample and is useful in specific diagnostic scenarios.
• Shave biopsy removes a superficial sample and is used selectively when appropriate.

All are done under local anaesthetic with clear wound-care advice. Any cut leaves a scar, yet careful planning of technique and closure helps minimise impact.

For a plain-English overview of what minor procedures involve under local anaesthetic, see Minor skin surgery. If the mole appears benign but causes problems such as snagging, catching or bleeding, we can discuss removal for comfort or function: Mole removal options.

Results and next steps: how long and what they mean

Most histopathology reports return in about two weeks. Timing varies with laboratory workload and whether any extra tests are needed. Your report guides the next step: reassurance and discharge if benign, or wider excision, further tests or ongoing monitoring if malignant or atypical.

Choosing NHS or private: a simple decision aid

• Risk and urgency – if melanoma is a concern, prioritise a prompt, high-quality dermoscopic assessment and a clear next step.
• Control and timing – if choosing a specific consultant dermatologist and a predictable appointment lowers anxiety and speeds decisions, private care may suit you.
• Complexity – previous melanoma, high-risk sites or multiple changing lesions often benefit from consultant-led review.
• Practicalities – consider travel, recovery time and help with aftercare.
• Continuity – you can move between routes; what matters is fast, expert assessment and clear communication.

This article provides general information only and is not a substitute for personalised medical advice. If you notice a fast-changing, bleeding or very dark lesion, arrange an urgent medical assessment.